Table 1.
Individuals | ||
---|---|---|
Healthy control group size | N | 23 |
Demographics | Age, median (range) | 33 (22-58) |
Male (n, %) | 15 (65%) | |
Female (n, %) | 8 (35%) | |
Pemphigus patients group size | N | 33 |
Demographics | Age, median (range) | 60 (41-83) |
Male (n, %) | 16 (48%) | |
Female (n, %) | 17 (52%) | |
Clinical status | Active | 9 (27%) |
Remission | 24 (73%) | |
Clinical phenotype | Mucosal | 9 (30%) |
Cutaneous | 4 (13%) | |
Mucocutaneous | 8 (27%) | |
None | 9 (30%) | |
Pemphigus specific HLA-types | HR DRβ1*0402 | 5 (25%) |
HR DQβ1*0503 | 7 (35%) | |
Both | 5 (25%) | |
None | 3 (15%) |
Demographics among PV patients include clinical status, clinical phenotype and pemphigus specific HLA-type.